Correspondence re: A. S. Lubbe et al., Preclinical experiences with magnetic drug targeting: Tolerance and efficacy. Cancer res., 56: 4694-4701, 1996; and Clinical experiences with magnetic drug targeting: A phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer res., 56: 4686-4693, 1996 (multiple letters)

Cancer Research

Volumn 57, Issue 14, 1997, Pages 3063-3065

  Gallo, J M ^a   Hafeli, U ^a   Lubbe, A S ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; IRON; MAGNETITE; ANTINEOPLASTIC ANTIBIOTIC;

ARTIFICIAL EMBOLISM; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG RELEASE; DRUG TARGETING; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LETTER; NONHUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOLID TUMOR; MAGNETISM; NEOPLASM; NOTE;

ANTIBIOTICS, ANTINEOPLASTIC; EPIRUBICIN; HUMANS; MAGNETICS; NEOPLASMS;

EID: 0031570959     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)